Global Advanced Therapy Medicinal Products Market
Pharmaceuticals

Advanced Therapy Medicinal Products Market Analysis With Focus On Growth Potential And Future Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Advanced Therapy Medicinal Products Market Projected To Reach By 2030?

The advanced therapy medicinal products market size has observed rapid expansion in recent years. It is forecast to rise from $51.34 billion in 2025 to $61.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.6%. The historical growth of this market can be ascribed to factors like limited availability of advanced therapy products, reliance on traditional biologics, nascent regulatory frameworks, the high cost of gene and cell therapies, and restricted distribution channels.

Significant expansion is projected for the advanced therapy medicinal products market in the upcoming years. By 2030, this market is predicted to attain a value of $124.43 billion, growing at a compound annual growth rate (CAGR) of 19.3%. This projected expansion can be linked to several factors, including breakthroughs in gene editing and stem cell therapies, increased funding for personalized medicine, a rise in the occurrence of rare and chronic conditions, the broadening of hospital pharmacy and specialty clinic infrastructures, and the incorporation of AI-powered manufacturing and automated procedures. Key trends expected during this period encompass the growing acceptance of both autologous and allogeneic treatments, the advancement of gene editing and viral vector innovations, an intensified emphasis on therapies for rare diseases, the incorporation of automation into therapy production, and increased partnerships between hospitals and specialized clinics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp

Which Key Factors Are Driving The Advanced Therapy Medicinal Products Market Growth?

The increasing need for personalized medicine is projected to propel the expansion of the advanced therapy medicinal products market in the coming years. Personalized medicine is defined as a medical approach that customizes treatment and prevention strategies to match an individual’s unique genetic profile, lifestyle, and environment. This growing demand for personalized medicine primarily stems from the rising occurrence of chronic diseases, as it facilitates individualized treatments that improve results and lessen side effects for patients. Advanced therapy medicinal products enable personalized medicine by offering bespoke treatments, such as gene, cell, and tissue-engineered therapies, which specifically target the distinct genetic and biological characteristics of individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. The newly cleared personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Therefore, the escalating demand for personalized medicine is a key driver for the growth of the advanced therapy medicinal products market.

Which Segment Classifications Are Used In The Advanced Therapy Medicinal Products Market Segment Analysis?

The advanced therapy medicinal products market covered in this report is segmented –

1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products

2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes

3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy

2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes

3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies

Which Trends Are Influencing Demand In The Advanced Therapy Medicinal Products Market?

Major companies operating in the advanced therapy medicinal products (ATMP) market are focusing on creating innovative treatments, such as gene editing cell therapies, to deliver targeted and potentially curative treatments for conditions like ß thalassemia and sickle cell disease. Gene editing cell therapies involve harvesting a patient’s hematopoietic stem cells and accurately modifying their genome ex vivo, frequently utilizing CRISPR Cas9 to correct detrimental mutations or activate beneficial genetic pathways, thus providing a personalized alternative to traditional allogeneic bone marrow transplantation, which depends on donor matching and poses risks such as graft versus host disease. For instance, in January 2024, Vertex Pharmaceuticals, a US based biotechnology company, received US Food and Drug Administration (FDA) approval for CASGEVY (exagamglogene autotemcel, or exa cel), a CRISPR Cas9 based gene editing cell therapy intended for transfusion dependent ß thalassemia. This therapy uses autologous CD34+ stem and progenitor cells, edits the erythroid specific BCL11A enhancer to increase fetal hemoglobin levels, and has demonstrated consistent clinical improvements, offering the potential to achieve transfusion independence for many patients and significantly reduce or eliminate the need for regular blood transfusions.

Which Firms Are Contributing To The Advanced Therapy Medicinal Products Market Ecosystem?

Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc

Get The Full Advanced Therapy Medicinal Products Market Report:

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-global-market-report

Which Region Has The Greatest Market Share In The Advanced Therapy Medicinal Products Market?

North America was the largest region in the advanced therapy medicinal products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Advanced Therapy Medicinal Products Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-global-market-report

Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Market 2026, By The Business Research Company

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Herbal Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/herbal-medicine-global-market-report

Anti Inflammatory Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model